COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

• Main Authors: Z. Ahmadinejad (Author), R. Assari (Author), N. Ayoobi Yazdi (Author), S.-H. Mazloomi (Author), P. Javanshayani (Author), H. Khalili Afousi (Author), V. Ziaee (Author)
• Format: Book
• Published: PAGEPress Publications, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The outbreak of coronavirus disease 2019 (COVID-19) has involved more than 159 countries and more than 5 million people worldwide. A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted wit...